36th Annual Aspen Allergy Conference
CREDIT CLAIMING IS NOW OPEN FOR THIS ACTIVITY. PLEASE REFER TO THE INSTRUCTIONS YOU RECEIVED VIA EMAIL, OR SCROLL DOWN ON THIS PAGE FOR THE PDF VERSION OF THE INSTRUCTIONS.
CREDIT CLAIMING WILL REMAIN OPEN THROUGH JUNE 30, 2019. CREDIT REQUESTS ON OR AFTER JULY 1, 2019 WILL BE SUBJECT TO AN ADMINISTRATIVE FEE.
The Aspen Allergy Conference is structured to host three State of the Art Speakers from around the United States and abroad each day. There is ample time for the speakers and attendees to discuss the basic science, translational and clnical topics at length during the course of the meeting. One oral abstract per day. In addition, several sessions are conducted for question and answer to include abstract poster session, “Meet the Professor” and a Nature Botany Walk.
Registration Fees
Attendee Type | Fee |
---|---|
Colorado Allergy & Asthma Society (CAAS) Member | FREE |
Speaking/Presenting Faculty | FREE |
Physician (not a member of CAAS) | $350 |
Pharmaceutical Representatives | $500 |
Online registration will remain open through 12:00 noon on Friday, July 20.
Credit claiming will be available through June 30, 2019. Credit requests on or after July 1, 2019 will be subject to an administrative fee.
Target Audience
- Allergist/immunologists
- Fellows-in-training
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe cutting-edge approaches to the most pressing issues in allergy/immunology, including precision medicine, asthma and environmental issues, immunodeficiency, and food allergy
- Analyze current medical practice and develop strategies to improve patient care across all relevant allergy/immunology topics
- Evaluate therapeutic options related to allergic disease and immune deficiency for effective treatment of patients with these conditions
Additional Information
Attachment | Size |
---|---|
![]() | 60.05 KB |
Main Program
Monday, July 23, 2018
SESSION I: Environmental Effects and Asthma
CHAIR:
1:00 - 1:05pm Welcome
Luke Webb, MD
Colorado Allergy & Asthma Society President
1:05 - 1:15 Harold Nelson, Moderator
Overview of Session/Reveal Disclosures
1:15 – 2:15 David Peden, MD
Professor, Department of Pediatrics, UNC School of Medicine, Chapel Hill, North Carolina
“Environmental Impact and Climate Change”
2:15 – 2:45 Abstract TBD
2:45 – 3:00 Coffee Break & Poster Session
3:00 – 4:00 Donata Vercelli, MD
Assistant Professor of Pediatrics, Department of Immunology, The University of Arizona Health Sciences, Tucson, Arizona
“Hutterites/Amish Effects on Pathogenesis of Asthma”
4:00 – 5:00 Thomas AE Platts-Mills, MD
Professor of Medicine and Microbiology, Allergy and Clinical Immunology, University of Virginia Health System, Charlottesville, Virginia
“Allergens and Asthma”
5:00 - 5:10 Harold Nelson, Moderator
Closing Comments/Adjournment
5:00 - 7:00 Interactive Poster Session/Symposium
Donna Bratton, Moderator
Tuesday, July 24, 2018
7:00 - 8:00 am Meet the Professor Thomas AE Platts Mills
David Pearlman, MD, Moderator
SESSION II: Precision Medicine and Check Point Interventions
CHAIR:
8:00 - 8:15 am Lanny Rosenwasser, Moderator
Overview of Session/Reveal Disclosures
8:15 - 9:15 Michail Lionakis, MD, ScD
Laboratory of Clinical Infectious Diseases, National Instiitute of Allergy and Infectious Diseases, Bethesda, Maryland
“Immune Mechanisms and Apeced”
9:15 - 9:45 ABSTRACT TBD
9:45 – 10:00 Coffee Break & Poster Session
10:00 – 11:00 William Kwok, PhD
Benaroya Research Institute at Virginia Mason Affiliate Associate Professor
Division of Allergy & Infectious Diseases, Department of Medicine, UW, Seattle, Washington
“Complex Adaptive Immune Response Mechanisms and Food Allergy -Unique TH2a Cells”
11:00 – 12:00 Meredith Buxton, MPH, PhD
Director, Clinical Trial Strategy, Berry Consultants Statistical Innovation, Austin, Texas
“Adaptive Trials”
12:00 – 12:15 Lanny Rosenwasser, Moderator
Closing Comments/Adjournment
12:15 – 2:15 Nature Botany Walk
Richard W. Weber, MD
Professor of Medicine, National Jewish Health, Denver, Colorado
Aspen Center for Environmental Studies
William Silvers, MD, Moderator
Wednesday, July 25, 2018
SESSION III: Immunodeficiency
CHAIR:
1:00 – 1:15 pm Charles H Kirkpatrick, MD, Moderator
Overview of Session/Reveal Disclosures
1:15 – 2:15 Deborah A. Meyers, PhD
Professor of Medicine, Co-Chief, Division of Genetics, Genomics and Precision Medicine, UA Department of Medicine, Co-Director, Division of Pharmacogenomics, UA Center for Applied Genetics and Genomic Medicine, The University of Arizona Health Sciences, Tucson, Arizona
“Genetics Primer and Epigenetics”
2:15 – 2:45 ABSTRACT
TBD
2:45 – 3:45 Thomas Fleisher, MD
Chief, Department of Laboratory Medicine, Chief, Immunology Service, National Institute of Health, Bethesda, Maryland
“Primary Immunodeficiency Syndromes”
3:45 – 4:15 Coffee Break & Poster Session
Ice Cream Social
4:15 – 5:15 Troy Torgerson, MD, PhD
Principal Investigator, Seattle Children’s Research Institute, Associate Professor, Department of Pediatrics
University of Washington, Seattle, Washington
“Treatment of Childhood Immunodeficiency”
5:15 – 5:20 Charles H Kirkpatrick, MD, Moderator
Closing Comments/ Adjournment
Thursday, July 26, 2018
7:00 - 8:00 am Meet the Professor
Kari Nadeau, MD
Dan Atkins, MD, Moderator
SESSION IV: Food Allergy
CHAIRS:
8:00 - 8:15 am John James, MD, Moderator
Overview of Session/Reveal Disclosures
8:15 - 9:15 Carina Venter, PhD, RD
Assistant Professor at University of Colorado, Children’s Hospital Colorado, Denver, Colorado
“Nutrition and Immune System”
9:15 – 10:15 Kari Nadeau, MD, PhD, FAAAAI
Director, Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Director, FARE Center of Excellence at Stanford University, Stanford, California
“Immunotherapy and Biologics, Multi-Allergen”
10:15 – 11:15 ABSTRACT
11:15 – 12:15 Glenn Furuta, MD
Director, Gastointestinal Eosinophilic Diseases Program, La Cache Endowed Chair for GI Allergic and Immunologic Diseases
Children’s Hospital Colorado, Aurora, Colorado
“Eosinophilic Esophagitis - EoE”
12:15 – 12:30 Lanny Rosenwasser, MD
“Conference Summary & Closing Comments”
Special Events
Family Members Welcome
Sunday, July 22, 2018
Henry Claman, MD Lecture
6:00 – 7:00 pm
Do New Tools Need New Ethics
Jeffrey Kahn, PhD, MPH
Andreas C Dracopoulos, Director, Johns Hopkins Berman Institute of Bioethics, Baltimore, Maryland
Reception
7:30 - 8:30 pm
Lik Aspen™
406 East Hopkins Avenue Ste B.
Monday, July 23, 2018
5 – 7 pm
Poster Abstract Session
Hotel Jerome Grand Ballroom
Tuesday, July 24, 2018
6 – 9 pm
President's Reception
Aspen Historical Society
620 West Bleeker Street
Walking Directions from the Hotel Jerome
Head west on E Main Street toward N Monarch St.
Turn right onto N Garmisch St
Turn left onto W Bleeker St – 620 W Bleeker on the right – 12 minute walk
Wednesday, July 25, 2018
8 - 10:30 am
Difficult Campground Bike Ride
CO-82, Aspen
Driving Directions from the Hotel Jerome
Head east on E Main St. towards S Mill St
Continue onto S Original St
Turn Left onto CO-82/E Cooper Ave.
Continue 3.6 miles - Turn right onto Difficult Campground – 12 minute drive
Planning Committee
Fred (Dan) Atkins, MD FAAAAI
Children's Hospital of Colorado, Aurora, CO
Relevant relationships: DBV Technologies
Stephen Dreskin, MD PhD FAAAAI
University of Colorado Denver, Denver, DO
Relevant relationships: None
Flavia Hoyte, MD
National Jewish Health, Denver, CO
Relevant relationships: None
John M. James, MD FAAAAI
Colorado Allergy and Asthma Centers, PC, Fort Collins, CO
Relevant relationships: None
Charles Kirkpatrick, MD FAAAAI
University of Colorado Health Science Center, Denver, CO
Relevant relationships: None
Harold S. Nelson, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Pearl Therapeutics, AstraZeneca (advisory board), ALK (speaker)
David Pearlman, MD FAAAAI
Colorado Allergy and Asthma Centers, PC, Denver, CO
Relevant relationships: GSK (consultant), Sanofi-Regeneron (honorarium)
Lanny Rosenwasser, MD FAAAAI
Chidren's Mercy Hospital, Kansas City, MO
Relevant relationships: None
Alan Schocket, MD MSHA
University of Colorado, Denver, CO
Relevant relationships: None
Gary Siegel, MD
Denver Allergy and Asthma, Lakewood, CO
Relevant relationships: None
William Silvers, MD FAAAAI
Private practice, Denver, CO
Relevant relationships: None
Richard Weber, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Merck (advisory board, TDI (advisory board)
Faculty
Fred (Dan) Atkins, MD FAAAAI
Children's Hospital of Colorado, Aurora, CO
Relevant relationships: DBV Technologies
Meredit Buxton, PhD
Berry Consultants, LLC
Relevant relationships: None
Thomas Fleisher, MD FAAAAI
National Institutes of Health, DHHS, Bethesda, MD
Relevant relationships: None
Glenn Furuta, MD
Children's Hospital of Colorado, Aurora, CO
Relevant relationships: EnteroTrack
John M. James, MD FAAAAI
Colorado Allergy and Asthma Centers, PC, Fort Collins, CO
Relevant relationships: None
Jeffrey Kahn, PhD
Johns Hopkins Berman Institute of Bioethics, Baltimore, MD
Relevant relationships: None
Charles Kirkpatrick, MD FAAAAI
University of Colorado Health Science Center, Denver, CO
Relevant relationships: None
William Kwok, PhD
Benaroya Research Institute, Seattle, WA
Relevant relationships: None
Michail Lionakis
National Institutes of Health, Bethesda, MD
Relevant relationships: None
Deborah Meyers, PhD FAAAAI
University of Arizona College of Medicine, Tucson, AZ
Relevant relationships: None
Kari Nadeau, MD PhD FAAAAI
Stanford University School of Medicine, Los Altos Hills, CA
Relevant relationships: Regeneron, AstraZeneca (consultant), Before Brands (co-founder, stock owner)
Harold S. Nelson, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Pearl Therapeutics, AstraZeneca (advisory board), ALK (speaker)
David Pearlman, MD FAAAAI
Colorado Allergy and Asthma Centers, PC, Denver, CO
Relevant relationships: GSK (consultant), Sanofi-Regeneron (honorarium)
Thomas Platts-Mills, MD PhD FAAAAI
University of Virginia, Charlottesville, VA
Relevant relationships: None
David Peden, MD MS FAAAAI
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
Relevant relationships: None
Lanny Rosenwasser, MD FAAAAI
Chidren's Mercy Hospital, Kansas City, MO
Relevant relationships: None
Troy Torgerson, MD PhD
University of Washington & Seattle Children's Research Institute, Seattle, WA
Relevant relationships: CSL Behring, UCB Pharmaceuticals, ADMA Biosciences, aTyr Pharmaceuticals, and Shire (consultant)
Carina Venter, PhD RD
University of Colorado/Children's Hospital of Colorado, Aurora, CO
Relevant relationships: Danone, Mead Johnson and Nestle (speaker), DBV Technologies (advisory board)
Donata Vercelli, MD
University of Arizona, Tucson, AZ
Relevant relationships: None
Richard Weber, MD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Merck (advisory board, TDI (advisory board)
Content Reviewers
Brian Kelly, MD
St. Paul Allergy and Asthma, St. Paul, MN
Relevant relationships: None
Brian Schroer, MD
Cleveland Clinic Foundation, Cleveland, OH
Relevant relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and Aspen Allergy Conference. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 16.00AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on June 30, 2019. Requests to claim credit on or after July 1, 2019 will be subject to an administrative fee.
AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.
Questions
Activity-related questions should be directed to Jill Hibbeln at Aspen Allergy Conference (jillhibbeln@gmail.com).
Registration and credit claiming questions should be directed to cme@aaaai.org.
Available Credit
- 16.00 AttendanceAttendance credit.
- 16.00 CMECME credit.
Price
CREDIT CLAIMING IS NOW OPEN FOR THIS ACTIVITY. PLEASE REFER TO THE INSTRUCTIONS YOU RECEIVED VIA EMAIL, OR DOWNLOAD THE INSTRUCTIONS AT THE BOTTOM OF THE OVERVIEW TAB.
CREDIT CLAIMING WILL REMAIN OPEN THROUGH JUNE 30, 2019. CREDIT REQUESTS ON OR AFTER JULY 1, 2019 WILL BE SUBJECT TO AN ADMINISTRATIVE FEE.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.
Internet Explorer is no longer supported.